Oculis Holding AG (OCS) Change in Account Payables (2022 - 2024)
Oculis Holding AG (OCS) recorded quarterly Change in Account Payables of $937189.4 in Q4 2024, down 52.79% quarter-over-quarter from $2.0 million in Q3 2024, and down 5.96% on a YoY basis from $996581.4 in Q1 2024.
Oculis Holding AG (OCS) Change in Account Payables (2022 - 2024) Analysis & Trends
Oculis Holding AG's Change in Account Payables history runs 3 years deep, the most recent figure standing at $937189.4 for Q4 2024.
- In Q4 2024, Change in Account Payables fell 5.96% year-over-year to $937189.4; the TTM figure through Dec 2024 stood at -$2.0 million (down 147.4% YoY), while the FY2024 annual figure was -$1.9 million, down 146.38% from the prior year.
- Change in Account Payables was $937189.4 for Q4 2024 at Oculis Holding AG, down from $2.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.5 million in Q4 2022 to a low of -$7.4 million in Q1 2024.
- Historically, Change in Account Payables has averaged $492757.3 across 3 years, with a median of $1.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables surged 527.44% in 2023, then plunged 215.5% in 2024.
- A 3-year view of Change in Account Payables shows it stood at $3.5 million in 2022, then slumped by 71.2% to $996581.4 in 2023, then dropped by 5.96% to $937189.4 in 2024.
- The last three Change in Account Payables figures came in at $937189.4 (Q4 2024), $2.0 million (Q3 2024), and $2.4 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -9.42 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 937,189.44 |
| Dec 31, 2024 | 937,189.44 |
| Sep 30, 2024 | 1.99 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | -7.36 Mn |
| Mar 31, 2024 | -7.36 Mn |
| Dec 31, 2023 | 996,581.35 |
| Dec 31, 2023 | 996,581.35 |
| Sep 30, 2023 | 3.37 Mn |
| Sep 30, 2023 | 3.37 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | -2.33 Mn |
| Mar 31, 2023 | -2.33 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Sep 30, 2022 | -787,982.50 |
| Sep 30, 2022 | -787,982.50 |